Emcure Pharma Live Share Price Today, Share Analysis and Chart

Name: Emcure Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Emcure Pharmaceuticals Ltd.
Rating: 2.98400
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

about

Emcure Pharmaceuticals Ltd. is a vertically integrated pharmaceutical company based in India with a significant global presence, particularly in the domestic, European, and Canadian markets. The company specializes in developing, manufacturing, and m...

1696.00 -29.30 (-1.70%)

38.01% Gain from 52W Low

233.8K

NSE+BSE Volume

NSE 29 May, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Moderately Bullish

61.2 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM

1,892

1Yr Price target upside is 12%

6 analysts

Emcure Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Emcure Pharma Live Share Price Today, Share Analysis and Chart

Emcure Pharmaceuticals Ltd. is a vertically integrated pharmaceutical company based in India with a significant global presence, particularly in the domestic, European, and Canadian markets. The company specializes in developing, manufacturing, and m...

38.01% Gain from 52W Low

SWOT Analysis

Emcure Pharma Live Price Chart